{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-070333","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2024-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.460654+00:00","generated_at":"2026-06-04T13:36:45.248932+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Eliem receives non-binding term sheet to acquire biotech Tango for $20M in stock","bullets":["RA Capital owns ~47.5% of Eliem and majority of Tango; special committee oversees strategic review.","Eliem valued at $110M, Tango at $20M; post-deal Tango holders get 15.4% of combined entity.","Concurrent PIPE financing to be sized by parties; RA Capital expected to participate.","Deal requires approval of majority of Eliem shares not held by RA Capital (non-waivable condition).","Non-binding; subject to due diligence, definitive agreement, and independent committee clearance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-070333","json":"https://secwatch.observer/filing/0001193125-24-070333.json","markdown":"https://secwatch.observer/filing/0001193125-24-070333.md","text":"https://secwatch.observer/filing/0001193125-24-070333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312524070333/0001193125-24-070333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312524070333/d784366d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T13:36:45.248932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}